What is EnPlusOne Biosciences worth?
$32.3Mlast known valuation
EnPlusOne Biosciences last raised $21.8M in its Early Stage VC (Aug 2022).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for EnPlusOne Biosciences
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2022 | Early Stage VC | $21.8M | ▮ | ▮ |
How EnPlusOne Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For EnPlusOne Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is EnPlusOne Biosciences worth?
- EnPlusOne Biosciences's last known valuation is $32.3M.
- How much has EnPlusOne Biosciences raised?
- EnPlusOne Biosciences has raised $21.8M in total funding across 1 recorded rounds.
- When did EnPlusOne Biosciences last raise?
- EnPlusOne Biosciences last raised in Aug 2022 (Early Stage VC), raising $21.8M.